ERBB2 and neoplasm: It is interesting to note that the same group demonstrated that HER2 epigenetically represses miR-205 transcription via the Ras/Raf/MEK/ERK pathway, likely to be a strategy exploited by tumor cells to counteract miR-205 oncosuppressive activity [43,44].